Skip to content

Randomized Controlled Clinical Trial To Evaluate Efficacy Of Vrandhavan , Vrandhupan And Vranlepan In Dushta Vrana w.s.r To Infected Wound .

Randomized controlled clinical trial to evaluate efficacy of Vranadhavan, Vranadhupan and Vranalepana in Dushta Vrana w.s.r. to infected wound. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104555
Enrollment
60
Registered
2026-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L984- Non-pressure chronic ulcer of skin, not elsewhere classified

Interventions

None listed

Sponsors

DrAjit Machindra Madke
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient age group of 18-60 yrs. 2.All patients irrespective of gender, occupation are taken. 3.Patient having sign and symptoms of Dushtavrana for 1-2 weeks having area upto Length 5cm x Breadth 5cm x Depth 5mm and restricted to localized area will be randomly selected.

Exclusion criteria

Exclusion criteria: 1.The patient who has underlying bony lesions. 2.Patients with malignant ulcer, tuberculous ulcer, lepromatous ulcer, gangrenous wound, bleeding disorders. 3.HIV, HbsAg positive patients. 4.Uncontrollable Diabetic Wound will not be selected

Design outcomes

Primary

MeasureTime frame
To evaluate efficiency of vrana dhavana,vrana dhupana and vrana lepana through a randomized controlled clinical trial in the management of dusta vranaTimepoint: To evaluate efficiency of vrana dhavana,vrana dhupana and vrana lepana through a randomized controlled clinical trial in the management of dusta vrana in 14 days

Secondary

MeasureTime frame
.To compare the rate of wound contraction and healing among Varan Dhavan, Varan Dhupan, and Varan Lepan. 2. To assess changes in wound characteristics such as discharge, odor, granulation tissue formation, and pain. 3. To evaluate the time required for complete healing in each intervention group. Timepoint: 12 days

Countries

India

Contacts

Public ContactDrAjit Machindra Madke

MES AYURVED MAHAVIDYALAYA

dryogeshborase@gmail.com8329008455

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026